Menu

Diseases From Ticks and Mosquitoes Have Tripled

Warmer weather is thought to be behind the rise in vector-borne illnesses in recent years.

May 1, 2018
Kerry Grens

ISTOCK, ANDRIANO_CZOver a little more than a decade, diseases from mosquitoes, ticks, and fleas have tripled in the U.S.—from about 27,000 cases in 2004 to more than 96,000 in 2016. That’s according to a report by the Centers for Disease Control and Prevention (CDC) published today (May 1). Scientists cite warmer weather as the driving force behind the increase.

“It enables these ticks to expand to new areas. Where there are ticks, there comes diseases,” Lyle Petersen, director of the CDC’s Division of Vector-Borne Diseases, tells Reuters. Neither Petersen nor the report say whether the data reflect the effects of climate change or global warming, The New York Times reports.

Although the incidence of vector-borne diseases rose steadily since 2004, 2016 experienced a huge spike in mosquito-borne disease compared to previous years because of the appearance of Zika, with 41,680 cases alone that year.

Tickborne illnesses went from around 22,000 in 2004 to more than 48,000 in 2016. Lyme disease is the most common sickness transmitted by ticks, accounting for more than 36,000 tickborne diseases in 2016.

These numbers likely far underestimate the true disease burden from these organisms, the report notes, because people don’t always seek care for the infections, which is how the CDC captures the data.

According to the Times, CDC director Robert Redfield advocated for more support for local public health departments, which the newspaper notes are “chronically underfunded.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!